Daily High to Daily Low: Is It Safe to Buy Immunic Inc. (IMUX)?

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Immunic Inc. (NASDAQ:IMUX) went down by -18.28% from its latest closing price compared to the recent 1-year high of $28.21. The company’s stock price has collected -24.33% of loss in the last five trading sessions. Press Release reported 18 hours ago that Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Immunic Inc. (NASDAQ :IMUX) Right Now?

Plus, the 36-month beta value for IMUX is at 2.19. Opinions of the stock are interesting as 6 analysts out of 6 who provided ratings for Immunic Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored



The average price from analysts is $60.83. IMUX currently public float of 14.93M and currently shorts hold a 6.31% ratio of that float. Today, the average trading volume of IMUX was 257.53K shares.

IMUX’s Market Performance

IMUX stocks went down by -24.33% for the week, with a monthly drop of -11.05% and a quarterly performance of -8.55%, while its annual performance rate touched 88.20%. The volatility ratio for the week stands at 17.37% while the volatility levels for the past 30 days are set at 9.31% for Immunic Inc.. The simple moving average for the period of the last 20 days is -11.41% for IMUX stocks with a simple moving average of 2.52% for the last 200 days.

Analysts’ Opinion of IMUX

Many brokerage firms have already submitted their reports for IMUX stocks, with SVB Leerink repeating the rating for IMUX by listing it as a “Outperform.” The predicted price for IMUX in the upcoming period, according to SVB Leerink is $45 based on the research report published on October 02nd of the previous year 2020.

Piper Sandler, on the other hand, stated in their research note that they expect to see IMUX reach a price target of $71. The rating they have provided for IMUX stocks is “Overweight” according to the report published on August 26th, 2020.

ROTH Capital gave a rating of “Buy” to IMUX, setting the target price at $64 in the report published on August 07th of the previous year.

IMUX Trading at -8.09% from the 50-Day Moving Average

After a stumble in the market that brought IMUX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.23% of loss for the given period.

Volatility was left at 9.31%, however, over the last 30 days, the volatility rate increased by 17.37%, as shares sank -5.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.60% lower at present.

During the last 5 trading sessions, IMUX fell by -24.33%, which changed the moving average for the period of 200-days by +103.19% in comparison to the 20-day moving average, which settled at $18.67. In addition, Immunic Inc. saw 8.44% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at IMUX starting from Whaley Glenn, who purchase 1,000 shares at the price of $18.96 back on Aug 10. After this action, Whaley Glenn now owns 1,000 shares of Immunic Inc., valued at $18,960 using the latest closing price.

Vitt Daniel, the Chief Executive Officer of Immunic Inc., sale 1,300 shares at $15.62 during a trade that took place back on Jul 21, which means that Vitt Daniel is holding 362,877 shares at $20,310 based on the most recent closing price.

Stock Fundamentals for IMUX

The total capital return value is set at -103.86, while invested capital returns managed to touch -97.98. Equity return is now at value -46.30, with -42.50 for asset returns.

Based on Immunic Inc. (IMUX), the company’s capital structure generated 0.89 points at debt to equity in total, while total debt to capital is 0.88. Total debt to assets is 0.79, with long-term debt to equity ratio resting at 0.89. Finally, the long-term debt to capital ratio is 0.88.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The liquidity ratio also appears to be rather interesting for investors as it stands at 4.56.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.